Literature DB >> 12695466

Warfarin for non-valvar atrial fibrillation: still underused in the 21st century?

S Bo, G Ciccone, L Scaglione, C Taliano, M Piobbici, F Merletti, G Pagano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695466      PMCID: PMC1767649          DOI: 10.1136/heart.89.5.553

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  3 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

3.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

Authors:  D C McCrory; D B Matchar; G Samsa; L L Sanders; E L Pritchett
Journal:  Arch Intern Med       Date:  1995-02-13
  3 in total
  3 in total

1.  Use of antithrombotic medications among elderly ischemic stroke patients.

Authors:  Judith H Lichtman; Lisa Naert; Norrina B Allen; Emi Watanabe; Sara B Jones; Lisa C Barry; Dawn M Bravata; Larry B Goldstein
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

Review 2.  Clinical and Economic Implications of AF Related Stroke.

Authors:  Ali N Ali; Ahmed Abdelhafiz
Journal:  J Atr Fibrillation       Date:  2016-02-29

3.  Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study.

Authors:  Simona Bo; Susanna Valpreda; Luca Scaglione; Daniela Boscolo; Marina Piobbici; Mario Bo; Giovannino Ciccone
Journal:  BMC Public Health       Date:  2007-08-10       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.